´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ ±Þ¼ºÀåÀÌ Àü¸ÁµÉ ¿¹Á¤ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀå ÃËÁø¿äÀÎÀº ½ÅÈï½ÃÀå¿¡ ÀÖ¾î¼ÀÇ ÀÇ·á ¾×¼¼½ºÀÇ °³¼±, ´ëµ¿¸Æ ¹ëºê ġȯ ±â¼úÀÇ Áøº¸ µîÀÔ´Ï´Ù. ÁÖ¿ä µ¿Çâ¿¡´Â ·Îº¿ Áö¿ø ¼ö¼ú, 3D È»ó°ú °¡½ÃÈ, °æ Ä«Å×ÅÍ ´ëµ¿¸Æ ¹ëºê ġȯ¼ú(TAVR)ÀÇ Çõ½Å, Áø´Ü¿¡ ÀÖ¾î¼ÀÇ ÀΰøÁö´ÉÀÇ ÅëÇÕ, »ýºÐÇØ¼º ½ºÅÙÆ®ÀÇ °³¹ß µîÀÌ ÀÖ½À´Ï´Ù.
½ÉÀå ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ÉºÎÀü, ºÎÁ¤¸Æ, ½ÉÀå ÆÇ¸·Áõ, ½É±ÙÁõ µîÀÌ ÀÖ½À´Ï´Ù. Ä«Å×ÅÍ ´ëµ¿¸Æ ÆÇ¸· À̽ļú(TAVI)°ú °°Àº Ä¡·á ¿É¼ÇÀº ÀûÀýÇÑ ½ÉÀå ±â´ÉÀ» ȸº¹½ÃŰ°í ½É°¢ÇÑ °á°úÀÇ À§ÇèÀ» ÁÙÀ̴µ¥ µµ¿òÀÌ µË´Ï´Ù. ¿¹¸¦ µé¾î, 2025³â 1¿ù ¿µ±¹ÀÇ ½ÉÇ÷°ü ¿¬±¸ ÀÚ¼±´ÜüÀÎ ¿µ±¹½ÉÀåÀç´ÜÀº ¿µ±¹¿¡¼ ¾à 760¸¸ ¸í(³²¼º ¾à 400¸¸ ¸í, ¿©¼º ¾à 360¸¸ ¸í)ÀÌ ½ÉÀå ¹× ¼øÈ¯°è ÁúȯÀ» ¾Î°í ÀÖ´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀº ¿µ±¹ Àüü »ç¸ÁÀÚÀÇ ¾à 27%¸¦ Â÷ÁöÇϸç, ¸Å³â 17¸¸ ¸í ÀÌ»ó, Áï ÇÏ·ç¿¡ ¾à 480¸íÀÌ »ç¸ÁÇÕ´Ï´Ù. ÀÌó·³ ½ÉÀå ÁúȯÀÇ ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.
´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå ÁÖ¿ä ±â¾÷Àº °æ Ä«Å×ÅÍ ´ëµ¿¸Æ ÆÇ¸· À̽Ä(TAVI) ½Ã½ºÅÛ°ú °°Àº ´ëµ¿¸Æ ÆÇ¸· ±â¼úÀÇ Áøº¸¿¡ ÃÊÁ¡À» ¸ÂÃß°í ȯÀÚ °á°ú¸¦ °³¼±Çϰí ÀýÂ÷ À§ÇèÀ» ÁÙÀ̰í Àü¹ÝÀûÀÎ Ä¡·á È¿°ú¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ±×·¸Áö ¾ÊÀ¸¸é Áúº´ÀÇ ´ëµ¿¸Æ ÆÇ¸·À» ´ëüÇϵµ·Ï ¼³°èµÈ Àú ħ½À ÀÇ·á±â±âÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 1¿ù, ¹Ì±¹¿¡ º»»ç¸¦ µÐ ÀÇ·á±â±â ȸ»çÀÎ Abbott Laboratories´Â ¹Ì±¹ ½ÄǰÀǾ౹(FDA)À¸·ÎºÎÅÍ ÃֽŠTAVI ½Ã½ºÅÛÀÎ Navitor¿¡ ´ëÇÑ ½ÂÀÎÀ» ¹Þ¾Ò½À´Ï´Ù. Navitor´Â ÆÇ¸· ÁÖÀ§ ´©ÃâÀ» ÃÖ¼ÒÈÇϰųª Á¦°ÅÇϵµ·Ï ¼³°èµÈ NaviSeal ÆÐºê¸¯ Ä¿ÇÁ°¡ Ư¡ÀÔ´Ï´Ù. ¶ÇÇÑ ³×ÀÌÆ¼ºê ¹ëºê ³»ÀÇ Àü´ÜÁö µðÀÚÀÎÀº ¹Ì·¡ÀÇ °ü»ó µ¿¸Æ Áúȯ Ä¡·á¸¦ À§ÇØ °ü»ó µ¿¸Æ Á¢±ÙÀ» °³¼±ÇÏ°í ´ëµ¿¸Æ ÇùÂøÁõÀ» °¡Áø ȯÀÚÀÇ Àå±â °ü¸®¸¦ Çâ»ó½ÃŰ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå Æ¯Â¡
Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«
Á¦4Àå ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°ÀÇ ¿µÇâ°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À
Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©
- ¼¼°èÀÇ ´ëµ¿¸Æ ÇùÂøÁõ PESTEL ºÐ¼®(Á¤Ä¡, »çȸ, ±â¼ú, ȯ°æ, ¹ýÀû ¿äÀÎ, ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ)
- ÃÖÁ¾ ÀÌ¿ë »ê¾÷ÀÇ ºÐ¼®
- ¼¼°èÀÇ ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå : ¼ºÀå·ü ºÐ¼®
- ¼¼°èÀÇ ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå ½ÇÀû : ±Ô¸ð¿Í ¼ºÀå(2019-2024³â)
- ¼¼°èÀÇ ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå ¿¹Ãø : ±Ô¸ð¿Í ¼ºÀå(2024-2029³â, 2034³â)
- ¼¼°èÀÇ ´ëµ¿¸Æ ÇùÂøÁõ Àüü ½ÃÀå(TAM)
Á¦6Àå ½ÃÀå ¼¼ºÐÈ
- ¼¼°èÀÇ ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå : À¯Çüº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
- ¼±Ãµ¼º ´ëµ¿¸Æ ÇùÂøÁõ
- ÈÄõ¼º ´ëµ¿¸Æ ÇùÂøÁõ
- ¼¼°èÀÇ ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå : Ä¡·áº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
- ¿Ü°úÀû ´ëµ¿¸Æ ÆÇ¸· ġȯ¼ú
- °æÇÇÀû ´ëµ¿¸Æ ÆÇ¸· ġȯ¼ú
- dz¼± ´ëµ¿¸Æ ÆÇ¸· ġȯ¼ú
- ¼¼°èÀÇ ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå : Åõ¿© °æ·Îº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
- °æ±¸
- ºñ°æ±¸
- ÀÓÇöõÆ®
- ¼¼°èÀÇ ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå : À¯Åë ä³Îº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
- ¿ÀÇÁ¶óÀÎ
- ¿Â¶óÀÎ
- ¼¼°èÀÇ ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
- ¿Â¶óÀÎ ¾à±¹
- ¼Ò¸Å ¾à±¹
- º´¿ø ¾à±¹
- ¼¼°èÀÇ ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå : ¼±Ãµ¼º ´ëµ¿¸Æ ÇùÂøÁõ À¯Çüº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
- ½Å»ý¾Æ ´ëµ¿¸Æ ÇùÂøÁõ
- ¿µ¾Æ ´ëµ¿¸Æ ÇùÂøÁõ
- û¼Ò³â ´ëµ¿¸Æ ÇùÂøÁõ
- ¼¼°èÀÇ ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå : ÈÄõ¼º ´ëµ¿¸Æ ÇùÂøÁõ À¯Çüº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
- ¿¬·É °ü·Ã ´ëµ¿¸Æ ÇùÂøÁõ
- ÅðÇ༺ ´ëµ¿¸Æ ÇùÂøÁõ
- ·ù¸¶Æ¼½º¼º ´ëµ¿¸Æ ÇùÂøÁõ
Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®
- ¼¼°èÀÇ ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå : Áö¿ªº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
- ¼¼°èÀÇ ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå : ±¹°¡º°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå
Á¦9Àå Áß±¹ ½ÃÀå
Á¦10Àå Àεµ ½ÃÀå
Á¦11Àå ÀϺ» ½ÃÀå
Á¦12Àå È£ÁÖ ½ÃÀå
Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå
Á¦14Àå Çѱ¹ ½ÃÀå
Á¦15Àå ¼À¯·´ ½ÃÀå
Á¦16Àå ¿µ±¹ ½ÃÀå
Á¦17Àå µ¶ÀÏ ½ÃÀå
Á¦18Àå ÇÁ¶û½º ½ÃÀå
Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå
Á¦20Àå ½ºÆäÀÎ ½ÃÀå
Á¦21Àå µ¿À¯·´ ½ÃÀå
Á¦22Àå ·¯½Ã¾Æ ½ÃÀå
Á¦23Àå ºÏ¹Ì ½ÃÀå
Á¦24Àå ¹Ì±¹ ½ÃÀå
Á¦25Àå ij³ª´Ù ½ÃÀå
Á¦26Àå ³²¹Ì ½ÃÀå
Á¦27Àå ºê¶óÁú ½ÃÀå
Á¦28Àå Áßµ¿ ½ÃÀå
Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå
Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ
- ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå : °æÀï ±¸µµ
- ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå : ±â¾÷ ÇÁ·ÎÆÄÀÏ
- AstraZeneca plc
- Abbott Laboratories
- Medtronic plc
- Boston Scientific Corporation
- Terumo Corporation
Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷
- Edwards Lifesciences Corporation
- BIoTronik SE & Co. KG
- LivaNova PLC
- Meril Life Sciences Pvt Ltd.
- Shockwave Medical Inc.
- Venus Medtech
- Egnite Inc.
- JenaValve Technology Inc
- Peijia Medical
- Micro Interventional Devices Inc
- CryoLife Inc.
- Coroneo Meril Life Sciences Pvt Ltd
- Thubrikar Aortic Valve Inc.
- Anteris Technologies Ltd.
- Cardiawave
Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå
Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)
Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ
Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, Àü·«
- ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå(2029³â) : »õ·Î¿î ±âȸ¸¦ Á¦°øÇÏ´Â ±¹°¡
- ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå(2029³â) : »õ·Î¿î ±âȸ¸¦ Á¦°øÇÏ´Â ºÎ¹®
- ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå(2029³â) : ¼ºÀå Àü·«
- ½ÃÀå µ¿Çâ¿¡ ÀÇÇÑ Àü·«
- °æÀï Àü·«
Á¦36Àå ºÎ·Ï
KTH
Aortic stenosis is a condition in which the aortic valve of the heart becomes narrowed, restricting blood flow from the left ventricle to the aorta and the rest of the body. It is commonly caused by age-related valve calcification, congenital valve defects, or rheumatic fever. Aortic stenosis can result in serious complications such as heart failure, which may be managed with medication or treated through surgical interventions such as valve replacement.
The primary types of aortic stenosis include congenital aortic stenosis and acquired aortic stenosis. Congenital aortic stenosis refers to a narrowing of the aortic valve present at birth, which limits blood flow from the heart's left ventricle to the aorta. Treatment options include surgical aortic valve replacement, transcatheter aortic valve replacement, and balloon aortic valvuloplasty. These treatments are administered through different methods such as oral, parenteral, and implants. Distribution channels are divided into offline and online platforms, while end users include hospital pharmacies, retail pharmacies, and online pharmacies.
The aortic stenosis market research report is one of a series of new reports from The Business Research Company that provides aortic stenosis market statistics, including aortic stenosis industry global market size, regional shares, competitors with an aortic stenosis market share, detailed aortic stenosis market segments, market trends and opportunities, and any further data you may need to thrive in the aortic stenosis industry. This aortic stenosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The aortic stenosis market size has grown rapidly in recent years. It will grow from $7.88 billion in 2024 to $8.93 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth during the historic period can be attributed to an aging population, a rising prevalence of risk factors, advancements in diagnostic technologies, increased awareness of heart diseases, and improvements in healthcare infrastructure.
The aortic stenosis market size is expected to see rapid growth in the next few years. It will grow to $14.54 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The projected growth in the forecast period is driven by the rising adoption of minimally invasive procedures, an expanding geriatric population, increasing healthcare expenditure, improved healthcare access in emerging markets, and advancements in aortic valve replacement technologies. Key trends include robotic-assisted surgery, 3D imaging and visualization, innovations in transcatheter aortic valve replacement (TAVR), the integration of artificial intelligence in diagnostics, and the development of biodegradable stents.
The rising prevalence of heart diseases is expected to drive the growth of the aortic stenosis market. Heart diseases encompass various conditions that affect the heart's structure and function, potentially impairing its ability to pump blood effectively and leading to severe complications. Common heart diseases include coronary artery disease (CAD), heart failure, arrhythmias, valvular heart disease, and cardiomyopathy. Aortic stenosis, a condition characterized by the narrowing of the aortic valve, obstructs blood flow from the left ventricle to the aorta, increasing resistance and forcing the heart to work harder, which can lead to heart failure and other cardiovascular issues over time. Treatment options such as valve replacement or transcatheter aortic valve implantation (TAVI) help restore proper heart function and reduce the risk of severe outcomes. For example, in January 2025, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are living with heart and circulatory diseases, including around 4 million males and 3.6 million females. These conditions account for nearly 27% of all deaths in the UK, leading to over 170,000 fatalities annually, or approximately 480 deaths per day. This increasing burden of heart diseases is driving the expansion of the aortic stenosis market.
Leading companies in the aortic stenosis market are focusing on advancements in aortic valve technologies, such as transcatheter aortic valve implantation (TAVI) systems, to improve patient outcomes, reduce procedural risks, and enhance overall treatment effectiveness. The TAVI system is a minimally invasive medical device designed to replace a diseased aortic valve without the need for open-heart surgery. For example, in January 2023, Abbott Laboratories, a US-based medical device company, received approval from the U.S. Food and Drug Administration (FDA) for Navitor, its latest-generation TAVI system. Navitor features the NaviSeal fabric cuff, designed to minimize or eliminate paravalvular leaks. Its leaflet design within the native valve aims to improve coronary artery access for potential future treatments of coronary artery disease, offering enhanced long-term care for patients with aortic stenosis.
In August 2024, Edwards Lifesciences, a US-based heart valve technologies company, expanded its structural heart portfolio through the acquisition of JC Medical for an undisclosed amount. This acquisition strengthens Edwards Lifesciences' capabilities in transcatheter aortic valve replacement (TAVR) technologies by incorporating the J-Valve system, a specialized solution for treating severe aortic regurgitation. JC Medical, a US-based medical device company, is known for developing advanced TAVI systems to address both aortic stenosis (AS) and aortic regurgitation (AR), further enhancing treatment options for patients with complex valvular conditions.
Major players in the aortic stenosis market are AstraZeneca plc, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, LivaNova PLC, Meril Life Sciences Pvt Ltd., Shockwave Medical Inc., Venus Medtech, Egnite Inc., JenaValve Technology Inc, Peijia Medical, Micro Interventional Devices Inc, CryoLife Inc., Coroneo Meril Life Sciences Pvt Ltd, Thubrikar Aortic Valve Inc., Anteris Technologies Ltd., Cardiawave.
North America was the largest region in the aortic stenosis market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in aortic stenosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the aortic stenosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The aortic stenosis market consists of revenues earned by entities by providing services such as surgical treatments, transcatheter aortic valve replacement, balloon valvuloplasty and medical management. The market value includes the value of related goods sold by the service provider or included within the service offering. The aortic stenosis market includes sales of medical devices, diagnostic and monitoring tools and surgical instruments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Aortic Stenosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on aortic stenosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for aortic stenosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The aortic stenosis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Congenital Aortic Stenosis; Acquired Aortic Stenosis
- 2) By Treatment: Surgical Aortic Valve Replacement; Transcatheter Aortic Valve Replacement; Balloon Aortic Valvuloplasty
- 3) By Administration: Oral; Parenteral; Implants
- 4) By Distribution Channel: Offline; Online
- 5) By End User: Online Pharmacy; Retail Pharmacy; Hospital Pharmacy
- Subsegments:
- 1) By Congenital Aortic Stenosis: Neonatal Aortic Stenosis; Infantile Aortic Stenosis; Juvenile Aortic Stenosis
- 2) By Acquired Aortic Stenosis: Age-Related Aortic Stenosis; Degenerative Aortic Stenosis; Rheumatic Aortic Stenosis
- Companies Mentioned: AstraZeneca plc; Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Terumo Corporation
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Aortic Stenosis Market Characteristics
3. Aortic Stenosis Market Trends And Strategies
4. Aortic Stenosis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Aortic Stenosis Growth Analysis And Strategic Analysis Framework
- 5.1. Global Aortic Stenosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Aortic Stenosis Market Growth Rate Analysis
- 5.4. Global Aortic Stenosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Aortic Stenosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Aortic Stenosis Total Addressable Market (TAM)
6. Aortic Stenosis Market Segmentation
- 6.1. Global Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Congenital Aortic Stenosis
- Acquired Aortic Stenosis
- 6.2. Global Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Surgical Aortic Valve Replacement
- Transcatheter Aortic Valve Replacement
- Balloon Aortic Valvuloplasty
- 6.3. Global Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Parenteral
- Implants
- 6.4. Global Aortic Stenosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Offline
- Online
- 6.5. Global Aortic Stenosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
- 6.6. Global Aortic Stenosis Market, Sub-Segmentation Of Congenital Aortic Stenosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Neonatal Aortic Stenosis
- Infantile Aortic Stenosis
- Juvenile Aortic Stenosis
- 6.7. Global Aortic Stenosis Market, Sub-Segmentation Of Acquired Aortic Stenosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Age-Related Aortic Stenosis
- Degenerative Aortic Stenosis
- Rheumatic Aortic Stenosis
7. Aortic Stenosis Market Regional And Country Analysis
- 7.1. Global Aortic Stenosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Aortic Stenosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Aortic Stenosis Market
- 8.1. Asia-Pacific Aortic Stenosis Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Aortic Stenosis Market
- 9.1. China Aortic Stenosis Market Overview
- 9.2. China Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Aortic Stenosis Market
- 10.1. India Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Aortic Stenosis Market
- 11.1. Japan Aortic Stenosis Market Overview
- 11.2. Japan Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Aortic Stenosis Market
- 12.1. Australia Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Aortic Stenosis Market
- 13.1. Indonesia Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Aortic Stenosis Market
- 14.1. South Korea Aortic Stenosis Market Overview
- 14.2. South Korea Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Aortic Stenosis Market
- 15.1. Western Europe Aortic Stenosis Market Overview
- 15.2. Western Europe Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Aortic Stenosis Market
- 16.1. UK Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Aortic Stenosis Market
- 17.1. Germany Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Aortic Stenosis Market
- 18.1. France Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Aortic Stenosis Market
- 19.1. Italy Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Aortic Stenosis Market
- 20.1. Spain Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Aortic Stenosis Market
- 21.1. Eastern Europe Aortic Stenosis Market Overview
- 21.2. Eastern Europe Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Aortic Stenosis Market
- 22.1. Russia Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Aortic Stenosis Market
- 23.1. North America Aortic Stenosis Market Overview
- 23.2. North America Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Aortic Stenosis Market
- 24.1. USA Aortic Stenosis Market Overview
- 24.2. USA Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Aortic Stenosis Market
- 25.1. Canada Aortic Stenosis Market Overview
- 25.2. Canada Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Aortic Stenosis Market
- 26.1. South America Aortic Stenosis Market Overview
- 26.2. South America Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Aortic Stenosis Market
- 27.1. Brazil Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Aortic Stenosis Market
- 28.1. Middle East Aortic Stenosis Market Overview
- 28.2. Middle East Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Aortic Stenosis Market
- 29.1. Africa Aortic Stenosis Market Overview
- 29.2. Africa Aortic Stenosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Aortic Stenosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Aortic Stenosis Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Aortic Stenosis Market Competitive Landscape And Company Profiles
- 30.1. Aortic Stenosis Market Competitive Landscape
- 30.2. Aortic Stenosis Market Company Profiles
- 30.2.1. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
31. Aortic Stenosis Market Other Major And Innovative Companies
- 31.1. Edwards Lifesciences Corporation
- 31.2. Biotronik SE & Co. KG
- 31.3. LivaNova PLC
- 31.4. Meril Life Sciences Pvt Ltd.
- 31.5. Shockwave Medical Inc.
- 31.6. Venus Medtech
- 31.7. Egnite Inc.
- 31.8. JenaValve Technology Inc
- 31.9. Peijia Medical
- 31.10. Micro Interventional Devices Inc
- 31.11. CryoLife Inc.
- 31.12. Coroneo Meril Life Sciences Pvt Ltd
- 31.13. Thubrikar Aortic Valve Inc.
- 31.14. Anteris Technologies Ltd.
- 31.15. Cardiawave
32. Global Aortic Stenosis Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Aortic Stenosis Market
34. Recent Developments In The Aortic Stenosis Market
35. Aortic Stenosis Market High Potential Countries, Segments and Strategies
- 35.1 Aortic Stenosis Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Aortic Stenosis Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Aortic Stenosis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer